| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Trishna Sharma, Annette C Kestner, Abhishek Redd. First Episode Psychosis in a Teen with Narcolepsy and Cataplexy. Psychopharmacology bulletin. vol 55. issue 1. 2025-01-02. PMID:39744411. |
narcolepsy with cataplexy (nt1) is a sleep disorder very rarely associated with early-onset psychosis. |
2025-01-02 |
2025-01-04 |
Not clear |
| Julie Martens, Maarten Van Den Bossch. Very late onset narcolepsy type 1: a case report and review of the literature. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2025-01-02. PMID:39745488. |
narcolepsy type 1 (nt1) is a clinical syndrome defined by recurrent episodes of excessive daytime sleepiness (eds), episodes of cataplexy, hypnagogic hallucinations, and sleep paralysis. |
2025-01-02 |
2025-01-04 |
Not clear |
| Jiaqin Yu, Yuyan Zhou, Xiao Han, Zongshan Li, Feiyan Chen, Lisan Zhan. Impaired Vigilance in Patients with Narcolepsy Type 1: A Psychomotor Vigilance Task Study. Nature and science of sleep. vol 16. 2024-12-18. PMID:39691443. |
vigilance is the main factor affecting daytime function in patients with narcolepsy type 1 (nt1). |
2024-12-18 |
2024-12-21 |
Not clear |
| Wenqi Xu, Wenting Ding, Yu Zhang, Shuanshuan Wang, Xianyu Yan, Yirui Xu, Xiaoying Zhi, Rongzeng Li. The Role of T Cells in the Pathogenesis of Narcolepsy Type 1: A Narrative Review. International journal of molecular sciences. vol 25. issue 22. 2024-11-27. PMID:39595997. |
narcolepsy type 1 (nt1) is an uncommon, persistent sleep disorder distinguished by significant daytime sleepiness, episodes of cataplexy, and irregularities in rapid eye movement sleep. |
2024-11-27 |
2024-11-29 |
Not clear |
| Marieke Vringer, Denise Bijlenga, Jingru Zhou, Onno C Meijer, Christiaan H Vinkers, Gert Jan Lammers, Rolf Froncze. Physiological and Psychological Stress Reactivity in Narcolepsy Type 1. Sleep. 2024-11-15. PMID:39546396. |
narcolepsy type 1 (nt1) is a chronic sleep-wake disorder, characterized by a loss of hypocretin production. |
2024-11-15 |
2024-11-18 |
Not clear |
| Shiqin Chen, Tian Lv, Zongshan Li, Gonghua Pan, Yiqiao Chen, Xingwang Zhao, Lisan Zhan. Associations between T-cell traits and narcolepsy type 1: new insights from a Mendelian randomization study. Frontiers in neurology. vol 15. 2024-11-15. PMID:39544989. |
narcolepsy type 1 (nt1) is primarily caused by a malfunctioning immune system in which t-cells damage the hypothalamus. |
2024-11-15 |
2024-11-17 |
Not clear |
| Huiqin Zhang, Lin Xu, Zhu Ai, Linlin Wang, Lu Wang, Lili Li, Ruilin Zhang, Rong Xue, Zuojun Wan. The brain topological alterations in the structural connectome and correlations with clinical characteristics in type 1 narcolepsy. NeuroImage. Clinical. vol 44. 2024-11-07. PMID:39509991. |
to explore topological alterations of white matter (wm) structural connectome, and their associations with clinical characteristics in type 1 narcolepsy (nt1). |
2024-11-07 |
2024-11-16 |
Not clear |
| Märt Vesinurm, Christina Dünweber, Jesper Rimestad, Anne-Marie Landtblom, Poul Jørgen Jennu. Patient experiences of narcolepsy and idiopathic hypersomnia in the Nordics: a patient journey map. Journal of sleep research. 2024-10-27. PMID:39462151. |
we aimed to explore the perspectives of individuals with narcolepsy type 1 (nt1), narcolepsy type 2 (nt2), and idiopathic hypersomnia (ih), and the challenges they encounter in their daily lives and within the healthcare systems in the nordics. |
2024-10-27 |
2024-10-30 |
Not clear |
| Niels Christian Haubjerg Østerby, Lone Baandrup, Poul Jørgen Jennu. Psychiatric comorbidity in Danish patients with narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a case-control study. Sleep advances : a journal of the Sleep Research Society. vol 5. issue 1. 2024-10-21. PMID:39430232. |
to examine the difference in psychiatric comorbidity of danish patients with narcolepsy type 1 (nt1), narcolepsy type 2 (nt2), and idiopathic hypersomnia (ih). |
2024-10-21 |
2024-10-23 |
Not clear |
| Pengxin Hu, Yuqing Yuan, Yu Zou, Ruifang Xiong, Jiankun Dai, Xihai Zhao, Liang Xie, Xiaoping Tan. Alterations in the DTI-ALPS index and choroid plexus volume are associated with clinical symptoms in participants with narcolepsy type 1. Sleep medicine. vol 124. 2024-10-20. PMID:39427503. |
narcolepsy type 1 (nt1) is a sleep disorder characterized by excessive daytime sleepiness accompanied by cataplexy. |
2024-10-20 |
2024-10-23 |
human |
| Gillian Heckler, Jennifer Worhach, Grace Wang, Klara Szilagyi, Bo Zhang, Cecilia Diniz Behn, Thomas Scammell, Kiran Mask. Characterizing disrupted nighttime sleep and associated functional outcomes in youth with narcolepsy type 1. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2024-10-17. PMID:39415540. |
disrupted nighttime sleep (dns) and sleep instability are common in children and adolescents with narcolepsy type 1 (nt1), but optimal objective sleep measures have not been determined. |
2024-10-17 |
2024-10-19 |
Not clear |
| Merve Aktan Suzgun, Elena S Wenz, Julia van der Meer, Livia G Fregolente, Jan D Warncke, Silvia Miano, Jens Acker, Mathias Strub, Elisabeth Olliges, Ramin Khatami, Markus H Schmidt, Claudio L A Bassetti, Sigrid von Manitiu. International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (iSPHYNCS): the impact of psychiatric comorbidities on daily life in central disorders of hypersomnolence-a vicious circle. Journal of sleep research. 2024-10-16. PMID:39410793. |
presence of psychiatric comorbidities is well documented in narcolepsy type-1 (nt1) but there are limited data on patients with 'other central disorders of hypersomnolence' (och). |
2024-10-16 |
2024-10-18 |
human |
| Louise Hjuler Andersen, Andreas Brink-Kjaer, Oliver Sum-Ping, Fabio Pizza, Francesco Biscarini, Niels Christian Haubjerg Østerby, Emmanuel Mignot, Giuseppe Plazzi, Poul J Jennu. Probabilistic Sleep Staging in MSLTs across Hypersomnia Disorders. Sleep. 2024-10-11. PMID:39392922. |
this study aimed to identify novel markers of narcolepsy type 1 (nt1) using between-nap opportunity periods ('lights on') and in-nap opportunity periods ('lights off') features of multiple sleep latency test (mslt) recordings. |
2024-10-11 |
2024-10-14 |
Not clear |
| Louise Hjuler Andersen, Andreas Brink-Kjaer, Oliver Sum-Ping, Fabio Pizza, Francesco Biscarini, Niels Christian Haubjerg Østerby, Emmanuel Mignot, Giuseppe Plazzi, Poul J Jennu. Probabilistic Sleep Staging in MSLTs across Hypersomnia Disorders. Sleep. 2024-10-11. PMID:39392922. |
further, we explored if mslts from nt1 and narcolepsy type 2 (nt2) patients could be distinguished despite having the same diagnostic thresholds. |
2024-10-11 |
2024-10-14 |
Not clear |
| Mengmeng Wang, Huanhuan Wang, Zhaoyan Feng, Shuai Wu, Bei Li, Fang Han, Fulong Xia. Predicting Depression Among Chinese Patients with Narcolepsy Type 1: A Machine-Learning Approach. Nature and science of sleep. vol 16. 2024-09-25. PMID:39318394. |
depression is a common psychiatric issue among patients with narcolepsy type 1 (nt1). |
2024-09-25 |
2024-09-27 |
Not clear |
| Francesco Biscarini, Chiara Bassi, Marco Menchetti, Corrado Zenesini, Valentina Baldini, Christian Franceschini, Giorgia Varallo, Elena Antelmi, Luca Vignatelli, Fabio Pizza, Giuseppe Plazzi, Francesca Ingravall. Co-occurrence of anxiety and depressive symptoms, suicidal thoughts, and hopelessness in patients with narcolepsy type 1. Sleep medicine. vol 124. 2024-09-19. PMID:39298876. |
to assesses the prevalence and co-occurrence of anxiety, depressive symptoms, suicidal thoughts, and hopelessness in patients with narcolepsy type 1 (nt1). |
2024-09-19 |
2024-09-22 |
Not clear |
| Matteo Conti, Flavia Cirillo, Silvia Maio, Mariana Fernandes, Roberta Bovenzi, Fabio Placidi, Francesca Izzi, Nicola Biagio Mercuri, Claudio Liguor. Increased neutrophil to lymphocyte ratio as a possible marker to detect neuroinflammation in patients with narcolepsy type 1. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2024-09-19. PMID:39297540. |
narcolepsy type 1 (nt1) is an autoimmune disease caused by the selective attack of orexin-producing neurons. |
2024-09-19 |
2024-09-26 |
Not clear |
| Lauren Daley, Prabhjyot Saini, Harrison Watters, Yasmine Bassil, Eric Schumacher, Lynn Marie Trotti, Shella Keilhol. Altered functional connectivity and spatiotemporal dynamics in individuals with sleep disorders. bioRxiv : the preprint server for biology. 2024-09-11. PMID:39257828. |
this study examines the observed functional connectivity in patients with ih, and patients with narcolepsy type 1 (nt1) against healthy control individuals. |
2024-09-11 |
2024-09-13 |
human |
| Marieke Vringer, Jingru Zhou, Jari K Gool, Denise Bijlenga, Gert Jan Lammers, Rolf Fronczek, Mink S Schinkelshoe. Recent insights into the pathophysiology of narcolepsy type 1. Sleep medicine reviews. vol 78. 2024-09-06. PMID:39241492. |
narcolepsy type 1 (nt1) is a sleep-wake disorder in which people typically experience excessive daytime sleepiness, cataplexy and other sleep-wake disturbances impairing daily life activities. |
2024-09-06 |
2024-09-10 |
Not clear |
| Kayo Mitsukawa, Michiko Terada, Ryuji Yamada, Taku Monjo, Tetsuaki Hiyoshi, Masanori Nakakariya, Yuichi Kajita, Tatsuya Ando, Tatsuki Koike, Haruhide Kimur. TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models. Scientific reports. vol 14. issue 1. 2024-09-06. PMID:39242684. |
narcolepsy type 1 (nt1) is associated with severe loss of orexin neurons and characterized by symptoms including excessive daytime sleepiness and cataplexy. |
2024-09-06 |
2024-09-10 |
mouse |